Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Clinical Breast Cancer|January 23, 2009
Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic optionsDavid Voduc, Torsten O NielsenCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic valueDavid Voduc, Maggie Cheang, Torsten NielsenSeminars in Radiation Oncology|March 4, 2008
Tissue microarrays in clinical oncologyDavid Voduc, Challayne Kenney, Torsten O NielsenHuman Pathology|July 16, 2008
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotypeDavid Voduc, Torsten O Nielsen, Maggie C Cheang, et al.Urology|March 11, 2006
Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002Scott Tyldesley, David Voduc, Michael McKenzie, et al.Breast Cancer Research and Treatment|November 22, 2017
Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-upKarama Asleh, Jennifer R Won, Dongxia Gao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Breast cancer subtypes and the risk of local and regional relapseK David Voduc, Maggie C U Cheang, Scott Tyldesley, et al.International Journal of Radiation Oncology, Biology, Physics|August 28, 2020
Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation SensitivityNafisha Lalani, K David Voduc, Rachel B Jimenez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Metastatic behavior of breast cancer subtypesHagen Kennecke, Rinat Yerushalmi, Ryan Woods, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.Pageof 3